探测心肌活力的技术进展

许长德

探测心肌活力的技术进展

许长德

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 6: (263-267)

引用本文:

Citation:

探测心肌活力的技术进展

许长德

200032 上海, 复旦大学中山医院核医学科

作者简介: 许长德(1973-),男,山东曹县人,博士研究生,主要从事核心脏病学研究。;

中图分类号: R542.2;R817.4

The development of imaging methods detecting the myocardial viability

XU Chang-de

Department of Nuclear Medicine, Zhongshan Hospital Medical Center of Fudan University, Shanghai 200032, China
CLC number: R542.2;R817.4

摘要: 心肌活力的评估十分重要,它有助于了解心肌病变患者的预后和选择治疗方式。评估心肌活力的方法包括核医学和其他临床上常见的方法,其中核医学上的方法有¹⁸F-FDG PET、¹⁸F-FDG SPECT、²⁰¹Tl SPECT、⁹⁹Tc^m-MIBI SPECT和脂肪酸显像,其他显像技术包括多巴酚丁胺负荷超声,MRI(核磁共振显像)等。
- 心肌活力 /
- 正电子发射体层显像 /
- 单光子发射计算机体层显像 /
- 核磁共振显像
Abstract: The measurement of the myocardial viability is important to evaluate the prognosis and select the operation pattern of the patients undergoing the coronary bypass surgery.Various techniques have been developed to identify viable myocardium including ¹⁸F-FDG PET,¹⁸F-FDG SPECT,²⁰¹Tl SPECT,⁹⁹Tc^m-sestamibi SPECT and fatty acid imaging in the nuclear medicine.The other clinical techniques including the dobutamine stress echocardiography and magnetic resonance imaging (MRI)methods can also assess myocardial viability.
- myocardial viability /
- positron emission tomography /
- single photon emission computed tomography /
- magnetic resonance imaging
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Hass F, Haehnl CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative risk in patients with advanced ischemic heart disease[J]. J Am Coll Cardiol, 1997, 30(7):1693-1700.
[2]	Gerber BL, Vanoverschelde JL, Bol A, et al. Myocardial blood flow, glucose uptake and recruitment for inotropic reserve in chronic left ventricular ischaemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation[J]. Circulation, 1996, 94(4):651-659.
[3]	Dicarli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischemic cardiomyopathy[J]. Circulation, 1995, 92(12):3436-3444.
[4]	Erie Q, Chen S, William J, et al. Myocardial viability studies using fluorine-18-FDG PET[J]. J Nucl Med, 1997, 38(4):582-586.
[5]	Srinivasan G, Kitsou AN, Bacharach SL, et al.[¹⁸F]Fluorodeoxyglucose single photon emission conmputered tomography:Can it replace PET and Thallium SPECT for the assessment of myocardial viability[J]. Circulation, 1998, 97(9):843-850.
[6]	Yamagishi H, Akioka K, Takagi M, et al. Exercise four hour redistribution thallium-201 single photon emission computed tomography and exercise induced ST segment elevation in detecting the viable myocardium in patients with acute myocardial infarction[J]. Heart, 1999, 81(1):17-24.
[7]	Duncan BH, Ahlberg AW, Levine MG, et al. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability[J]. Am J Cardiol, 2000, 85(6):680-684.
[8]	Kaltoft A, Bottcher M, Sand NP, et al. ⁹⁹Tc^m-Sestamibi SPECT is a useful technique for viability detection:results of a comparison with NH₃/FDG PET[J]. Scand Cardiovasc J, 2001, 35(4):245-251.
[9]	Altehoefer C, Dahl JV, Messmer BJ, et al. Fate of the resting perfusion defect as assessed with technetium-99m methoxy-isobutyl-isonitrile single-photon emission computed tomography after successful revascularization in patients with healed myocardial infarction[J]. Am J Cardiol, 1996, 77(1):88-92.
[10]	Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with ¹²³I fatty acid and ²⁰¹Tl to assess ischemic myocardium:comparison with thallium redistribution and glucose metabolism[J]. Ann Nucl Med, 1994, 8(1):47-54.
[11]	Knapp FF, Franken P, Kropp J, et al. Cardiac SPECT with iodine-123-labeled fatty acids:evaluation of myocardial viability with BMIPP[J]. J Nucl Med, 1995, 36(6):1022-1030.
[12]	Keiichiro Y, Koichi M, Satohi Y, et al. Low-dose dobutamine electrocardiography-gated myocardial SPECT for identifying viable myocardium:Comparison with dobutamine stress echocardiography and PET[J]. J Nucl Med, 2001, 42:838-844.
[13]	Sozzi FB, Poldermans D, Bax JJ, et al. Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography[J]. Heart, 2001, 86(6):672-678.
[14]	Zaglavara T, Haaverstad R, Cumberledge B, et al. Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking β blockers:accuracy and optimal dose[J]. Heart, 2002, 87(4):329-335.
[15]	Charles BH. Prediction of myocardial viability by MRI[J]. Circulation, 1999, 99(6):727-729.
[16]	Rogers WJ, Kramer CM, Geskin G, et al. Early contrastenhanced MRI predicts late functional recovery after reperfused myocardial infarction[J]. Circulation, 1999, 99(6):744-750.
[17]	Wahba FF, Lamb HJ, Bax JJ, et al. Assessment of regional myocardial wall motion and thickening by gated ⁹⁹Tc^m-tetrofosmin SPECT:a comparison with magnetic resonance imaging[J]. Nucl Med Commun, 2001, 22(6):663-671.

[1]	余永利 , 朱瑞森 . 单光子灌注显像评估心肌活力. 国际放射医学核医学杂志, 1995, 19(6): 253-256.
[2]	余永利 , 朱瑞森 . 代谢性显像评估心肌活力. 国际放射医学核医学杂志, 1995, 19(6): 250-253.
[3]	李文罡 , 陈绍亮 . 门控断层显像在心肌灌注断层显像中的应用. 国际放射医学核医学杂志, 2001, 25(6): 253-258.
[4]	曾骏 , 林祥通 , 赵惠杨 . 放射性碘标记游离脂肪酸单光子显像评价活性心肌的尝试. 国际放射医学核医学杂志, 1995, 19(6): 247-249.
[5]	吴震宇 . 核素显像在肝癌临床诊断中的应用. 国际放射医学核医学杂志, 2004, 28(5): 199-202.
[6]	张凯军 . SPECT脑血流及介入显像在痴呆诊断中的临床应用进展. 国际放射医学核医学杂志, 2002, 26(4): 159-162.
[7]	袁志斌 . 正电子肿瘤阳性显像剂¹⁸F-AMT. 国际放射医学核医学杂志, 2002, 26(5): 193-195.
[8]	陈永辉 , 李方 . 双探头符合线路¹⁸F-FDG显像在肺癌诊断中的作用. 国际放射医学核医学杂志, 2002, 26(6): 260-262,267.
[9]	袁志斌 . PET显像在内分泌肿瘤中的应用. 国际放射医学核医学杂志, 2003, 27(5): 208-211.
[10]	张军 . ¹¹C-flumazenil受体显像在缺血半暗带研究中的进展. 国际放射医学核医学杂志, 2004, 28(6): 246-249.

点击查看大图

计量

文章访问数: 993
HTML全文浏览量: 139
PDF下载量: 2

探测心肌活力的技术进展

许长德

作者简介:许长德(1973-),男,山东曹县人,博士研究生,主要从事核心脏病学研究。

200032 上海, 复旦大学中山医院核医学科

收稿日期: 2002-08-05

关键词:

摘要: 心肌活力的评估十分重要,它有助于了解心肌病变患者的预后和选择治疗方式。评估心肌活力的方法包括核医学和其他临床上常见的方法,其中核医学上的方法有¹⁸F-FDG PET、¹⁸F-FDG SPECT、²⁰¹Tl SPECT、⁹⁹Tc^m-MIBI SPECT和脂肪酸显像,其他显像技术包括多巴酚丁胺负荷超声,MRI(核磁共振显像)等。